Histopathology image evaluation is indispensable for cancer diagnoses and subtype classification. Standard artificial intelligence methods for histopathology image analyses have focused on optimizing specialized models for each diagnostic task1,2. Although such methods have achieved some success, they often have limited generalizability to images generated by different digitization protocols or samples collected from different populations3. Here, to address this challenge, we devised the Clinical Histopathology Imaging Evaluation Foundation (CHIEF) model, a general-purpose weakly supervised machine learning framework to extract pathology imaging features for systematic cancer evaluation. CHIEF leverages two complementary pretraining methods to extract diverse pathology representations: unsupervised pretraining for tile-level feature identification and weakly supervised pretraining for whole-slide pattern recognition. We developed CHIEF using 60,530 whole-slide images spanning 19 anatomical sites. Through pretraining on 44 terabytes of high-resolution pathology imaging datasets, CHIEF extracted microscopic representations useful for cancer cell detection, tumour origin identification, molecular profile characterization and prognostic prediction. We successfully validated CHIEF using 19,491 whole-slide images from 32 independent slide sets collected from 24 hospitals and cohorts internationally. Overall, CHIEF outperformed the state-of-the-art deep learning methods by up to 36.1%, showing its ability to address domain shifts observed in samples from diverse populations and processed by different slide preparation methods. CHIEF provides a generalizable foundation for efficient digital pathology evaluation for patients with cancer. A study describes the development of a generalizable foundation machine learning framework to extract pathology imaging features for cancer diagnosis and prognosis prediction.
基金:
AWS Cloud Credits for Research programme; Microsoft Azure for Research Award programme; NVIDIA GPU Grant Program; National Institute of General Medical Sciences [R35GM142879]; Department of Defense Peer Reviewed Cancer Research Program Career Development Award [HT9425-231-0523, RSG-24-1253761-01-ESED]; American Cancer Society; Google Research Scholar Award; Harvard Medical School Dean's Innovation Award; Blavatnik Center for Computational Biomedicine Award; National Institutes of Health [P50CA165962]; Cure Foundation; Seoul National University Hospital - Ministry of Health and Welfare, Republic of Korea [HI18C0316]
第一作者机构:[1]Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA[2]Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
共同第一作者:
通讯作者:
通讯机构:[1]Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA[2]Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA[16]Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA[23]Harvard Univ, Harvard Data Sci Initiat, Cambridge, MA 02138 USA
推荐引用方式(GB/T 7714):
Wang Xiyue,Zhao Junhan,Marostica Eliana,et al.A pathology foundation model for cancer diagnosis and prognosis prediction[J].NATURE.2024,doi:10.1038/s41586-024-07894-z.
APA:
Wang, Xiyue,Zhao, Junhan,Marostica, Eliana,Yuan, Wei,Jin, Jietian...&Yu, Kun-Hsing.(2024).A pathology foundation model for cancer diagnosis and prognosis prediction.NATURE,,
MLA:
Wang, Xiyue,et al."A pathology foundation model for cancer diagnosis and prognosis prediction".NATURE .(2024)